Friday, September 30, 2016

Streptomycin





To reduce the development of drug-resistant bacteria and maintain the effectiveness of Streptomycin and other antibacterial drugs, Streptomycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.



Warning

THE RISK OF SEVERE NEUROTOXIC REACTIONS IS SHARPLY INCREASED IN PATIENTS WITH IMPAIRED RENAL FUNCTION OR PRE-RENAL AZOTEMIA. THESE INCLUDE DISTURBANCES OF VESTIBULAR AND COCHLEAR FUNCTION, OPTIC NERVE DYSFUNCTION, PERIPHERAL NEURITIS, ARACHNOIDITIS, AND ENCEPHALOPATHY MAY ALSO OCCUR. THE INCIDENCE OF CLINICALLY DETECTABLE, IRREVERSIBLE VESTIBULAR DAMAGE IS PARTICULARLY HIGH IN PATIENTS TREATED WITH Streptomycin.


RENAL FUNCTION SHOULD BE MONITORED CAREFULLY; PATIENTS WITH RENAL IMPAIRMENT AND/OR NITROGEN RETENTION SHOULD RECEIVE REDUCED DOSES. THE PEAK SERUM CONCENTRATION IN INDIVIDUALS WITH KIDNEY DAMAGE SHOULD NOT EXCEED 20 TO 25 MCG/ML.


THE CONCURRENT OR SEQUENTIAL USE OF OTHER NEUROTOXIC AND/OR NEPHROTOXIC DRUGS WITH Streptomycin SULFATE, INCLUDING NEOMYCIN, KANAMYCIN, GENTAMICIN, CEPHALORIDINE, PAROMOMYCIN, VIOMYCIN, POLYMYXIN B, COLISTIN, TOBRAMYCIN AND CYCLOSPORINE SHOULD BE AVOIDED.


THE NEUROTOXICITY OF Streptomycin CAN RESULT IN RESPIRATORY PARALYSIS FROM NEUROMUSCULAR BLOCKAGE, ESPECIALLY WHEN THE DRUG IS GIVEN SOON AFTER THE USE OF ANESTHESIA OR MUSCLE RELAXANTS.


THE ADMINISTRATION OF Streptomycin IN PARENTERAL FORM SHOULD BE RESERVED FOR PATIENTS WHERE ADEQUATE LABORATORY AND AUDIOMETRIC TESTING FACILITIES ARE AVAILABLE DURING THERAPY.




Streptomycin Description


Streptomycin is a water-soluble aminoglycoside derived from Streptomyces griseus. It is marketed as the sulfate salt of Streptomycin. The chemical name of Streptomycin sulfate is D-Streptamine, O - 2 - deoxy - 2 - (methylamino) - α - L - glucopyranosyl - (1→2) - O - 5 - deoxy - 3 - C - formyl - α - L - lyxofuranosyl - (1→4) - N,N1 - bis(aminoiminomethyl) - ,sulfate (2:3) (salt). The molecular formula for Streptomycin Sulfate is (C21H39N7O12)2 -3H2SO4 and the molecular weight is 1457.41. It has the following structural formula:



Streptomycin for Injection USP, equivalent to 1 gram Streptomycin /vial is supplied as a sterile nonpyrogenic lyophillized cake for intramuscular use after reconstitution. The lyophillized cake may reduce to a powder during shipping.


After reconstitution the pH range for Streptomycin for Injection USP should be between 4.5 and 7.0 in a solution containing 200 mg of Streptomycin activity per mL.


*Each vial contains Sterile Streptomycin Sulfate USP equivalent to 1 gram of Streptomycin.



Streptomycin - Clinical Pharmacology


Following intramuscular injection of 1 g of Streptomycin as the sulfate, a peak serum level of 25 to 50 mcg/mL is reached within 1 hour, diminishing slowly to about 50 percent after 5 to 6 hours.


Appreciable concentrations are found in all organ tissues except the brain. Significant amounts have been found in pleural fluid and tuberculous cavities. Streptomycin passes through the placenta with serum levels in the cord blood similar to maternal levels. Small amounts are excreted in milk, saliva, and sweat.


Streptomycin is excreted by glomerular filtration. In patients with normal kidney function, between 29% and 89% of a single 600 mg dose is excreted in the urine within 24 hours. Any reduction of glomerular function results in decreased excretion of the drug and concurrent rise in serum and tissue levels



Microbiology


Streptomycin sulfate is a bactericidal antibiotic. It acts by interfering with normal protein synthesis.


Streptomycin has been shown to be active against most strains of the following organisms both in vitro and in clinical infection. (See INDICATIONS AND USAGE.):



  • Brucella (brucellosis),




  • Calymmatobacterium granulomatis (donovanosis, granuloma inguinale),




  • Escherichia coli, Proteus spp., Aerobacter aerogenes, Klebsiella pneumoniae, and Enterococcus faecalis in urinary tract infections,




  • Francisella tularensis,




  • Haemophilus ducreyi (chancroid),




  • Haemophilus influenzae (in respiratory, endocardial, and meningeal infections - concomitantly with another antibacterial agent),




  • Klebsiella pneumoniae pneumonia (concomitantly with another antibacterial agent),




  • Mycobacterium tuberculosis,




  • Pasteurella pestis




  • Streptococcus viridans, Enterococcus faecalis (in endocardial infections - concomitantly with penicillin).




SUSCEPTIBILITY TESTS: Diffusion Techniques


Quantitative methods that require measurement of zone diameters give the most precise estimate of the susceptibility of bacteria to antimicrobial agents. One such standard procedure1 which has been recommended for use with disks to test susceptibility of organisms to Streptomycin uses the 10 mcg Streptomycin disk. Interpretation involves the correlation of the diameter obtained in the disk test with the minimum inhibitory concentration (MIC) for Streptomycin.


Reports from the laboratory giving results of the standard single disk susceptibility test with a 10 mcg Streptomycin disk should be interpreted according to the following criteria:



















ZoneDiameter(mm)                    Interpretation
>15                    (S)Susceptible
11-12                    (I)Intermediate
<10                    (R)Resistant

A report of “Susceptible” indicates that the pathogen is likely to respond to monotherapy with Streptomycin. A report of “Intermediate” indicates that the result be considered equivocal, and, if the organism is not fully susceptible to alternative clinically feasible drugs, the test should be repeated. This category provides a buffer zone which prevents small uncontrolled technical factors from causing major discrepancies in interpretations. A report of “Resistant” indicates that achievable drug concentrations are unlikely to be inhibitory and other therapy should be selected.


Standardized procedures require the use of laboratory control organisms. The 10 mcg Streptomycin disk should give the following zone diameter:



















Organism                    ZoneDiameter(mm)
E.coliATCC25922                    12-20
S.aureusATCC25923                    14-22
Methods Section:

Two standardized in vitro susceptibility methods are available for testing Streptomycin against Mycobancerium tuberculosis organisms. The agar proportion method (CDC or NCCLS M24-P) utilizes middlebrook 7H10 medium impregnated with Streptomycin at two final concentrations, 2.0 and 10.0 mcg/mL. MIC90 values are calculated by comparing the quantity of organisms growing in the medium containing drug to the control cultures. Mycobacterial growth in the presence of drug > 1% of the control indicates resistance.


The radiometric broth method employs the BACTEC 460 machine to compare the growth index from untreated control cultures to cultures grown in the presence of 6.0 mcg/mL of Streptomycin. Strict adherence to the manufacturer’s instructions for sample processing and data interpretation is required for this assay.


Susceptibility test results obtained by these two different methods cannot be compared unless equivalent drug concentrations are evaluated.


The clinical relevance of in vitro susceptibility test results for mycobacterial species other than M. tuberculosis using either the BACTEC or the proportion method has not been determined.



Indications and Usage for Streptomycin


Streptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptibile strains of microorganisms in the specific conditions listed below:



  1. Mycobacterium tuberculosis: The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Center for Disease Control recommend that either Streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH or rifampin resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. In the past when the national rate of primary drug resistance to isoniazid was known to be less than 4% and was either stable or declining, therapy with two and three drug regimens was considered adequate. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.


    Streptomycin is also indicated for therapy of tuberculosis when one or more of the above drugs is contraindicated because of toxicity or intolerance. The management of tuberculosis has become more complex as a consequence of increasing rates of drug resistance and concomitant HIV infection. Additional consultation from experts in the treatment of tuberculosis may be desirable in those settings.




  2. Non-tuberculosis infections: The use of Streptomycin should be limited to the treatment of infections caused by bacteria which have been shown to be susceptible to the antibacterial effects of Streptomycin and which are not amenable to therapy with less potentially toxic agents.



    1. Pasteurella pestis (plague),




    2. Francisella tularensis (tularemia),




    3. Brucella,




    4. Calymmatobacterium granulomatis (donovanosis, granuloma inguinale),




    5. H. ducreyi (chancroid),




    6. H. influenzae (in respiratory, endocardial, and meningeal infections-concomitantly with another antibacterial agent),




    7. K. pneumoniae pneumonia (concomitantly with another antibacterial agent),




    8. E.coli, Proteus, A. aerogenes, K. pneumoniae, and Enterococcus faecalis in urinary tract infections,




    9. Streptococcus viridans, Enterococcus faecalis (in endocardial infections -concomitantly with penicillin),




    10. Gram-negative bacillary bacteremia (concomitantly with another antibacterial agent).




To reduce the development of drug-resistant bacteria and maintain the effectiveness of Streptomycin and other antibacterial drugs, Streptomycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.



Contraindications


A history of clinically significant hypersensitivity to Streptomycin is a contraindication to its use. Clinically significant hypersensitivity to other aminoglycosides may contraindicate the use of Streptomycin because of the known cross-sensitivity of patients to drugs in this class.



Warnings


Ototoxicity: Both vestibular and auditory dysfunction can follow the administration of Streptomycin. The degree of impairment is directly proportional to the dose and duration of Streptomycin administration, to the age of the patient, to the level of renal function and to the amount of underlying existing auditory dysfunction. The ototoxic effects of the aminoglycosides, including Streptomycin, are potentiated by the co-administration of ethacrynic acid, mannitol, furosemide and possibly other diuretics.


The vestibulotoxic potential of Streptomycin exceeds that of its capacity for cochlear toxicity. Vestibular damage is heralded by headache, nausea, vomiting and disequilibrium. Early cochlear injury is demonstrated by the loss of high frequency hearing. Appropriate monitoring and early discontinuation of the drug may permit recovery prior to irreversible damage to the sensorineural cells.


Pregnancy: Streptomycin can cause fetal harm when administered to a pregnant woman. Because Streptomycin readily crosses the placental barrier, caution in use of the drug is important to prevent ototoxicity in the fetus. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.



Precautions



General


Prescribing Streptomycin in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.


Baseline and periodic caloric stimulation tests and audiometric tests are advisable with extended Streptomycin therapy. Tinnitus, roaring noises, or a sense of fullness in the ears indicates need for audiometric examination or termination of Streptomycin therapy or both.


Care should be taken by individuals handling Streptomycin for injection to avoid skin sensitivity reactions. As with all intramuscular preparations, Streptomycin Sulfate Injection should be injected well within the body of a relatively large muscle and care should be taken to minimize the possibility of damage to peripheral nerves. (See DOSAGE AND ADMINISTRATION.)


Extreme caution must be exercised in selecting a dosage regimen in the presence of pre-existing renal insufficiency. In severely uremic patients a single dose may produce high blood levels for several days and the cumulative effect may produce ototoxic sequelae. When Streptomycin must be given for prolonged periods of time alkalinization of the urine may minimize or prevent renal irritation.


A syndrome of apparent central nervous system depression, characterized by stupor and flaccidity, occasionally coma and deep respiratory depression, has been reported in very young infants in whom Streptomycin dosage had exceeded the recommended limits. Thus, infants should not receive Streptomycin in excess of the recommended dosage.


In the treatment of venereal infections such as granuloma inguinale, and chancroid, if concomitant syphilis is suspected, suitable laboratory procedures such as a dark field examination should be performed before the start of treatment, and monthly serologic tests should be done for at least four months.


As with other antibiotics, use of this drug may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be instituted.



Information for Patients


Patients should be counseled that antibacterial drugs including Streptomycin should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Streptomycin is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Streptomycin or other antibacterial drugs in the future.



Drug Interactions


The ototoxic effects of the aminoglycosides, including Streptomycin, are potentiated by the co-administration of ethacrynic acid, furosemide, mannitol and possibly other diuretics.



Pregnancy


Category D: See WARNINGS section.



Nursing Mothers


Because of the potential for serious adverse reactions in nursing infants from Streptomycin, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.



Pediatric Use


(See DOSAGE AND ADMINISTRATION.)



Adverse Reactions


The following reactions are common: vestibular ototoxicity (nausea, vomiting, and vertigo); paresthesia of face; rash; fever; urticaria; angioneurotic edema; and eosinophilia.


The following reactions are less frequent: cochlear ototoxicity (deafness); exfoliative dermatitis; anaphylaxis; azotemia; leucopenia; thrombocytopenia; pancytopenia; hemolytic anemia; muscular weakness; and amblyopia.


Vestibular dysfunction resulting from the parenteral administration of Streptomycin is cumulatively related to the total daily dose. When 1.8 to 2 g/day are given, symptoms are likely to develop in the large percentage of patients - especially in the elderly or patients with impaired renal function - within four weeks. Therefore, it is recommended that caloric and audiometric tests be done prior to, during, and following intensive therapy with Streptomycin in order to facilitate detection of any vestibular dysfunction and/or impairment of hearing which may occur.


Vestibular symptoms generally appear early and usually are reversible with early detection and cessation of Streptomycin administration. Two to three months after stopping the drug, gross vestibular symptoms usually disappear, except from the relative inability to walk in total darkness or on very rough terrain.


Although Streptomycin is the least nephrotoxic of the aminoglycosides, nephrotoxicity does occur rarely.


Clinical judgment as to termination of therapy must be exercised when side effects occur.



Streptomycin Dosage and Administration



Intramuscular Route Only


Adults: The preferred site is the upper outer quadrant of the buttock, (i.e., gluteus maximus), or the mid-lateral thigh.


Children: It is recommended that intramuscular injections be given preferably in the mid-lateral muscles of the thigh. In infants and small children the periphery of the upper outer quadrant of the gluteal region should be used only when necessary, such as in burn patients, in order to minimize the possibility of damage to the sciatic nerve.


The deltoid area should be used only if well developed such as in certain adults and older children, and then only with caution to avoid radial nerve injury. Intramuscular injections should not be made into the lower and mid-third of the upper arm. As with all intramuscular injections, aspiration is necessary to help avoid inadvertent injection into a blood vessel.


Injection sites should be alternated. As higher doses or more prolonged therapy with Streptomycin may be indicated for more severe or fulminating infections (endocarditis, meningitis, etc.), the physician should always take adequate measures to be immediately aware of any toxic signs or symptoms occurring in the patient as a result of Streptomycin therapy.



  1. TUBERCULOSIS: The standard regimen for the treatment of drug susceptible tuberculosis has been two months of INH, rifampin and pyrazinamide followed by four months of INH and rifampin (patients with concomitant infection with tuberculosis and HIV may require treatment for a longer period). When Streptomycin is added to this regimen because of suspected or proven drug resistance (see INDICATIONS AND USAGE section), the recommended dosing for Streptomycin is as follows:








































              Daily                    TwiceWeekly          ThriceWeekly
    Children          20-40 mg/kg          25-30 mg/kg          25-30 mg/kg
              Max 1 g          Max 1.5 g          Max 1.5 g
    Adults          15 mg/kg          25-30 mg/kg          25-30 mg/kg
              Max 1 g          Max 1.5 g          Max 1.5 g

    Streptomycin is usually administered daily as a single intramuscular injection. A total dose of not more than 120 g over the course of therapy should be given unless there are no other therapeutic options. In patients older than 60 years of age the drug should be used at a reduced dosage due to the risk of increased toxicity. (See BOXED WARNING.)


    Therapy with Streptomycin may be terminated when toxic symptoms have appeared, when impending toxicity is feared, when organisms become resistant, or when full treatment effect has been obtained. The total period of drug treatment of tuberculosis is a minimum of 1 year; however, indications for terminating therapy with Streptomycin may occur at any time as noted above.




  2. TULAREMIA: One to 2 g daily in divided doses for 7 to 14 days until the patient is afebrile for 5 to 7 days.




  3. PLAGUE: Two grams of Streptomycin daily in two divided doses should be administered intramuscularly. A minimum of 10 days of therapy is recommended.




  4. BACTERIAL ENDOCARDITIS:


    Streptococcal endocarditis; in penicillin-sensitive alpha and non-hemolytic streptococcal endocarditis (penicillin MIC<0.1 mcg/mL), Streptomycin may be used for 2-week treatment concomitantly with penicillin. The Streptomycin regimen is 1 g b.i.d. for the first week, and 500 mg b.i.d. for the second week. If the patient is over  60 years of age, the dosage should be 500 mg b.i.d. for the entire 2- week period.


    Enterococcal endocarditis: Streptomycin in doses of 1 g b.i.d. for 2 weeks and 500 mg b.i.d. for an additional 4 weeks is given in combination with penicillin. Ototoxicity may require termination of the Streptomycin prior to completion of the 6-week course of treatment.




  5. CONCOMITANT USE WITH OTHER AGENTS: For concomitant use with other agents to which the infecting organism is also sensitive: Streptomycin is considered a secondline agent for the treatment of gram-negative bacillary bactermia, meningitis, and pneumonia; brucellosis; granuloma inguinale; chancroid, and urinary tract infection.



For adults: 1 to 2 grams in divided doses every six to twelve hours for moderate to severe infections. Doses should generally not exceed 2 grams per day.


For children: 20 to 40 mg/kg/day (8 to 20 mg/lb/day) in divided doses every 6 to 12 hours. (Particular care should be taken to avoid excessive dosage in children).


The dry lyophillized cake is dissolved by adding Water for Injection USP in an amount to yield the desired concentration as indicated in the following table:



















Approx.Conc.mg/mL                    Volume(mL)ofSolvent
200                    4.2
250                    3.2
400                    1.8

Sterile reconstituted solutions should be protected from light and may be stored at room temperature for one week without significant loss of potency


Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit



How is Streptomycin Supplied


Streptomycin for Injection USP is available in vials containing 1 gram. NDC 39822-0706-1. Boxes of ten vials use NDC 39822-0706-2.



STORAGE


Store dry powder under controlled room temperature 15°-30°C (59°-86°F).


PROTECT FROM LIGHT



REFERENCES


1National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests-Fourth Edition. Approved Standard NCCLS Document M2-A4.Vol.10, No.7, NCCLS, Villanova, PA 1990.


Manufactured for:


X-Gen Pharmaceuticals, Inc.


Northport, NY 11768








Streptomycin 
Streptomycin  injection, powder, lyophilized, for solution










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)39822-0706
Route of AdministrationINTRAMUSCULARDEA Schedule    








INGREDIENTS
Name (Active Moiety)TypeStrength
Streptomycin (Streptomycin)Active1 GRAM  In 1 VIAL


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
139822-0706-210 VIAL In 1 BOXcontains a VIAL (39822-0706-1)
139822-0706-11 VIAL In 1 VIALThis package is contained within the BOX (39822-0706-2)

Revised: 10/2006X-Gen Pharmaceuticals, Inc.

More Streptomycin resources


  • Streptomycin Side Effects (in more detail)
  • Streptomycin Use in Pregnancy & Breastfeeding
  • Streptomycin Drug Interactions
  • Streptomycin Support Group
  • 0 Reviews for Streptomycin - Add your own review/rating


  • Streptomycin MedFacts Consumer Leaflet (Wolters Kluwer)

  • streptomycin Intramuscular Advanced Consumer (Micromedex) - Includes Dosage Information

  • Streptomycin Sulfate Monograph (AHFS DI)



Compare Streptomycin with other medications


  • Brucellosis
  • Endocarditis
  • Mycobacterium avium-intracellulare, Treatment
  • Plague
  • Rabbit Fever
  • Tuberculosis, Active

Ser-Ap-Es


Generic Name: hydralazine/hydrochlorothiazide/reserpine (hye DRAL a zeen/hye droe klor oh THYE a zide/re SER peen)

Brand Names: Diuretic Ap-Es, Hydrap-ES, Ser-Ap-Es, Serpazide, Tri-Hydroserpine, Uni Serp


What is Ser-Ap-Es (hydralazine/hydrochlorothiazide/reserpine)?

Hydralazine is a vasodilator. It lowers blood pressure by relaxing (widening) blood vessels (veins and arteries) and making it easier for your heart to pump.


Hydrochlorothiazide is a thiazide diuretic (water pill). It helps to lower your blood pressure and decrease edema (swelling or water retention) by increasing the amount of salt and water you lose in your urine.


Reserpine lowers blood pressure by decreasing the levels of certain chemicals in your blood. This allows your blood vessels (veins and arteries) to relax and your heart to beat more slowly and easily.


The combination, hydralazine/hydrochlorothiazide/reserpine, is used to lower high blood pressure.


Hydralazine/hydrochlorothiazide/reserpine may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about Ser-Ap-Es (hydralazine/hydrochlorothiazide/reserpine)?


Stand up slowly from a sitting or lying position. Hydralazine/hydrochlorothiazide/reserpine may make you feel dizzy. Do not stop taking hydralazine/hydrochlorothiazide/reserpine suddenly. Even if you feel better, you need this medication to control your condition. Stopping suddenly could cause severely high blood pressure, anxiety, and other dangerous side effects. Use caution when driving, operating machinery, or performing other hazardous activities. Hydralazine/hydrochlorothiazide/reserpine may cause dizziness. If you experience dizziness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while you are taking this medication.

What should I discuss with my healthcare provider before taking Ser-Ap-Es (hydralazine/hydrochlorothiazide/reserpine)?


Do not take hydralazine/hydrochlorothiazide/reserpine without first talking to your doctor if you

  • have an allergy to sulfa-based drugs such as sulfa antibiotics;




  • have coronary heart disease or mitral valvular rheumatic heart disease;




  • have peptic ulcer disease (stomach ulcers);




  • have ulcerative colitis;




  • are suffering from depression (especially if you have suicidal thoughts);




  • are receiving electroconvulsive shock therapy; or




  • have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days.



You may not be able to take hydralazine/hydrochlorothiazide/reserpine if you have any of the conditions listed above.


Before taking this medication, tell your doctor if you



  • have gallstones,



  • have kidney or liver disease,


  • have diabetes,




  • have gout,




  • have a collagen vascular disease such as systemic lupus erythematosus,




  • have pancreatitis,




  • have asthma,




  • have any type of heart disease,




  • have had a stroke or a transient ischemic attack (mini-stroke),




  • have high cholesterol or high levels of fat in your blood, or




  • have pulmonary hypertension (a type of lung disease).



You may require a dosage adjustment or special monitoring during therapy with hydralazine/hydrochlorothiazide/reserpine if you have any of the conditions listed above.


Hydralazine/hydrochlorothiazide/reserpine is in the FDA pregnancy category C. This means that it is not known whether hydralazine/hydrochlorothiazide/reserpine will harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant. Hydralazine/hydrochlorothiazide/reserpine passes into breast milk and may harm a nursing infant. Do not take this medication without first talking to your doctor if you are breast-feeding a baby. If you are over 60 years of age, you may be more likely to experience side effects from hydralazine/hydrochlorothiazide/reserpine therapy. You may require a lower dose of this medication.

How should I take Ser-Ap-Es (hydralazine/hydrochlorothiazide/reserpine)?


Take the medication exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Take each dose with a full glass of water. Take the medication with food or milk if it upsets your stomach.

Do not suddenly stop taking hydralazine/hydrochlorothiazide/reserpine. Stopping suddenly could make your condition much worse or cause very serious side effects. Talk to your doctor before you stop taking this medication.


Store this medication at room temperature away from moisture and heat.

See also: Ser-Ap-Es dosage (in more detail)

What happens if I miss a dose?


Take the missed dose as soon as you remember. However, if it is almost time for your next dose, skip the dose you missed and take only your next regularly scheduled dose. Do not take a double dose of this medication.


What happens if I overdose?


Seek emergency medical attention.

Symptoms of an overdose include low blood pressure (fainting, dizziness, weakness), slow pulse or an irregular heartbeat, low body temperature, diarrhea, increased urination, vomiting, headache, flushing of the skin, and slow breathing.


What should I avoid while taking Ser-Ap-Es (hydralazine/hydrochlorothiazide/reserpine)?


Use caution when driving, operating machinery, or performing other hazardous activities. This medicine may cause dizziness. If you experience dizziness, avoid these activities. Avoid alcohol while taking hydralazine/hydrochlorothiazide/reserpine. Alcohol may increase the drowsiness caused by this medication and may increase dizziness. Use caution even with small amounts of alcohol. Use caution when rising from a sitting or lying position, especially first thing in the morning. You may become dizzy while taking hydralazine/hydrochlorothiazide/reserpine, and you may fall and injure yourself.

Do not let yourself become overheated in hot weather or during exercise, and use caution if you have a fever. Dehydration may increase the effects of hydralazine/hydrochlorothiazide/reserpine, and you may become very dizzy.


Avoid prolonged exposure to sunlight. Hydrochlorothiazide may increase the sensitivity of your skin to sunlight. Use a sunscreen and wear protective clothing when exposure to the sun is unavoidable.

Ser-Ap-Es (hydralazine/hydrochlorothiazide/reserpine) side effects


If you experience any of the following serious side effects, stop taking hydralazine/hydrochlorothiazide/reserpine and seek emergency medical attention:

  • an allergic reaction (difficulty breathing, closing of your throat, swelling of your lips, tongue or face, hives);




  • irregular or fast heartbeats or a fluttering feeling in your chest;




  • new or worsening chest pain;




  • heart failure (shortness of breath, swelling of ankles or legs, sudden weight gain of 2 pounds in one day or 5 pounds in one week);




  • unusual fatigue or confusion;




  • abnormal bleeding or bruising;




  • yellow skin or eyes;




  • blood in your urine or stools;




  • little or no urine;




  • numbness, tingling, pain, or weakness of your arms or legs; or




  • fainting.



Other, less serious side effects are more likely to occur. Continue to take hydralazine/hydrochlorothiazide/reserpine and talk to your doctor if you experience



  • mild fatigue, drowsiness, or dizziness;




  • headache;




  • water retention (swelling of the hands, feet, or ankles);




  • anxiety, depression, or nightmares;




  • diarrhea, nausea, vomiting , abdominal pain;




  • stuffy nose or a dry mouth;




  • muscle weakness or cramps;




  • increased hunger, thirst, or urination;




  • a rash;




  • sensitivity to sunlight; or



  • impotence or difficulty ejaculating.

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.


What other drugs will affect Ser-Ap-Es (hydralazine/hydrochlorothiazide/reserpine)?


Do not take this medication if you have taken a monoamine oxidase inhibitor (MAOI), such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate), in the last 14 days.


Before taking this medication, tell your doctor if you are taking any of the following drugs:



  • digoxin (Lanoxin, Lanoxicaps);




  • quinidine (Cardioquin, others);




  • lithium (Lithobid, Eskalith, others);



  • a tricyclic antidepressant such as amitriptyline (Elavil, Endep), imipramine (Tofranil), nortriptyline (Pamelor), doxepin (Sinequan), and others;

  • a nonsteroidal anti-inflammatory drug (NSAID) such as ibuprofen (Motrin, Advil), ketoprofen (Orudis, Orudis KT, Oruvail), naproxen (Naprosyn, Anaprox, Aleve), and others;


  • an antidiabetic medicine such as glipizide (Glucotrol), glyburide (Micronase, Glynase, Diabeta), and others; or




  • a steroid medicine such as prednisone (Orasone, Deltasone), prednisolone (Delta Cortef, Prelone), methylprednisolone (Medrol), and others.



You may not be able to take hydralazine/hydrochlorothiazide/reserpine, or you may require a dosage adjustment or special monitoring during your treatment if you are taking any of the medicines listed above.


Also, before taking hydralazine/hydrochlorothiazide/reserpine, tell your doctor if you are taking any medicine to treat high blood pressure, water retention, heart problems, prostate problems, or another condition. Some medicines used to treat these conditions may interact with hydralazine/hydrochlorothiazide/reserpine, and the interaction may increase the effects on your heart.


Hydralazine/hydrochlorothiazide/reserpine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, antihistamines, sedatives (used to treat insomnia), pain relievers, anxiety medicines, and muscle relaxants. Tell your doctor about all medicines that you are taking, and do not take any medicine unless your doctor approves.


Drugs other than those listed here may also interact with hydralazine/hydrochlorothiazide/reserpine or affect your condition. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.



More Ser-Ap-Es resources


  • Ser-Ap-Es Side Effects (in more detail)
  • Ser-Ap-Es Dosage
  • Ser-Ap-Es Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ser-Ap-Es Drug Interactions
  • Ser-Ap-Es Support Group
  • 0 Reviews for Ser-Ap-Es - Add your own review/rating


  • Ser-Ap-Es Prescribing Information (FDA)



Compare Ser-Ap-Es with other medications


  • High Blood Pressure


Where can I get more information?


  • Your pharmacist has additional information about hydralazine/hydrochlorothiazide/reserpine written for health professionals that you may read.

What does my medication look like?


Hydralazine/hydrochlorothiazide/reserpine is available with a prescription under the brand name Ser-Ap-Es. Other brand or generic formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.


Hydralazine/hydrochlorothiazide/reserpine strengths are as follows:



  • Ser-Ap-Es (25 mg/15 mg/0.1mg)--round, salmon-pink, dry-coated tablets



See also: Ser-Ap-Es side effects (in more detail)


Sular


Generic Name: nisoldipine (Oral route)

nye-SOL-di-peen

Commonly used brand name(s)

In the U.S.


  • Sular

Available Dosage Forms:


  • Tablet, Extended Release

Therapeutic Class: Cardiovascular Agent


Pharmacologic Class: Calcium Channel Blocker


Chemical Class: Dihydropyridine


Uses For Sular


Nisoldipine is used alone or together with other medicines to treat high blood pressure. High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also increase the risk of heart attacks. These problems may be less likely to occur if blood pressure is controlled .


Nisoldipine is a calcium channel blocker. It works by affecting the movement of calcium into the cells of the heart and blood vessels. As a result, it relaxes blood vessels and increases the supply of blood and oxygen to the heart while reducing its workload .


This medicine is available only with your doctor's prescription.


Before Using Sular


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of nisoldipine in the pediatric population. Safety and efficacy have not been established ..


Geriatric


Appropriate studies performed to date have not demonstrated geriatrics-specific problems that would limit the usefulness of nicardipine in the elderly. However, elderly patients are more likely to have age-related kidney, liver, or heart problems which may require an adjustment of dose in patients receiving nisoldipine .


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Itraconazole

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Amiodarone

  • Dantrolene

  • Mibefradil

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acebutolol

  • Alprenolol

  • Atenolol

  • Betaxolol

  • Bevantolol

  • Bisoprolol

  • Bucindolol

  • Carteolol

  • Carvedilol

  • Celiprolol

  • Cimetidine

  • Clopidogrel

  • Dalfopristin

  • Digoxin

  • Dilevalol

  • Esmolol

  • Fosphenytoin

  • Indinavir

  • Ketoconazole

  • Labetalol

  • Levobunolol

  • Mepindolol

  • Metipranolol

  • Metoprolol

  • Nadolol

  • Nebivolol

  • Oxprenolol

  • Penbutolol

  • Phenytoin

  • Pindolol

  • Propranolol

  • Quinidine

  • Quinupristin

  • Rifampin

  • Rifapentine

  • Sotalol

  • St John's Wort

  • Talinolol

  • Tertatolol

  • Timolol

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following may cause an increased risk of certain side effects but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use this medicine, or give you special instructions about the use of food, alcohol, or tobacco.


  • Grapefruit Juice

Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Congestive heart failure or

  • Coronary artery disease or

  • Low blood pressure—Use with caution. May increase risk of serious side effects .

  • Liver disease—Use with caution. The effects of nisoldipine may be increased because of the slower removal of the medicine from the body .

Proper Use of Sular


In addition to the use of this medicine, treatment for your high blood pressure may include weight control and changes in the types of foods you eat, especially foods high in sodium. Your doctor will tell you which of these are most important for you. You should check with your doctor before changing your diet .


Many patients who have high blood pressure will not notice any signs of the problem. In fact, many may feel normal. It is very important that you take your medicine exactly as directed and that you keep your appointments with your doctor even if you feel well .


Remember that this medicine will not cure your high blood pressure, but it does help control it. You must continue to take it as directed if you expect to lower your blood pressure and keep it down. You may have to take high blood pressure medicine for the rest of your life. If high blood pressure is not treated, it can cause serious problems such as heart failure, blood vessel disease, stroke, or kidney disease .


Take this medicine exactly as directed even if you feel well. Do not take more of this medicine and do not take it more often than your doctor ordered. This medicine works best if there is a constant amount in the blood. To keep blood levels constant, take this medicine at the same time each day and do not miss any doses.


Swallow the extended release tablet whole. Do not break, crush, or chew it. It is best to take this medicine on an empty stomach .


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (extended release tablets):
    • For high blood pressure:
      • Adults—10 to 20 milligrams (mg) once a day. Your doctor may increase your dose if needed.

      • Children—Use and dose must be determined by your doctor .



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Sular


It is important that your doctor check your progress at regular visits to make sure this medicine is working properly and to check for unwanted effects .


It is very important that your doctor check your blood regularly while you are taking this medicine. You may also need to monitor your blood pressure at home. If you notice any changes to your recommended blood pressure, call your doctor right away .


Low blood pressure (hypotension) may occur while taking this medicine. Check with your doctor right away if you have the following symptoms: blurred vision; confusion; severe dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly; sweating; or unusual tiredness or weakness .


This medicine may cause dizziness, lightheadedness, or fainting. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you experience these effects.


Nisoldipine should not be taken with a high-fat meal or with grapefruit juice or other grapefruit products because these may increase the levels of nisoldipine in the body .


Sular Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Bloating or swelling of face, arms, hands, lower legs, or feet

  • rapid weight gain

  • tingling of hands or feet

  • unusual weight gain or loss

Less common
  • Chest pain

  • dizziness, lightheadedness, or fainting

  • fast, irregular, pounding, or racing heartbeat or pulse

  • feeling of warmth or heat

  • flushing or redness of skin, especially on face and neck

  • headache

  • rash

  • sweating

Rare
  • Chest tightness

  • shortness of breath

  • swelling of the arms, face, legs, lips, tongue, or throat

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Body aches or pain

  • congestion

  • cough

  • dryness or soreness of throat

  • fever

  • heartbeat sensations

  • hoarseness

  • pain or tenderness around eyes and cheekbones

  • runny nose

  • stuffy nose

  • tender, swollen glands in neck

  • trouble in swallowing

  • voice changes

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Sular side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Sular resources


  • Sular Side Effects (in more detail)
  • Sular Use in Pregnancy & Breastfeeding
  • Drug Images
  • Sular Drug Interactions
  • Sular Support Group
  • 1 Review for Sular - Add your own review/rating


  • Sular Prescribing Information (FDA)

  • Sular Extended-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Sular Concise Consumer Information (Cerner Multum)

  • Sular Monograph (AHFS DI)

  • Nisoldipine Prescribing Information (FDA)

  • Nisoldipine Professional Patient Advice (Wolters Kluwer)



Compare Sular with other medications


  • Angina Pectoris Prophylaxis
  • High Blood Pressure
  • Raynaud's Syndrome

Sulconazole Nitrate Solution


Pronunciation: sul-KON-a-zole
Generic Name: Sulconazole Nitrate
Brand Name: Exelderm


Sulconazole Nitrate Solution is used for:

Treating fungal infections, such as jock itch, ringworm, and tinea versicolor (a fungal infection affecting the skin of the upper arms, chest, back, and sometimes the neck and face).


Sulconazole Nitrate Solution is an antifungal. It works by blocking the growth of fungi.


Do NOT use Sulconazole Nitrate Solution if:


  • you are allergic to any ingredient in Sulconazole Nitrate Solution

Contact your doctor or health care provider right away if any of these apply to you.



Before using Sulconazole Nitrate Solution:


Some medical conditions may interact with Sulconazole Nitrate Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

Some MEDICINES MAY INTERACT with Sulconazole Nitrate Solution. Because little, if any, of Sulconazole Nitrate Solution is absorbed into the blood, the risk of it interacting with another medicine is low.


This may not be a complete list of all interactions that may occur. Ask your health care provider if Sulconazole Nitrate Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Sulconazole Nitrate Solution:


Use Sulconazole Nitrate Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • To clear up your infection completely, continue using Sulconazole Nitrate Solution for the full course of treatment.

  • Sulconazole Nitrate Solution is for external use only.

  • Clean the affected area with soap and water and dry thoroughly. Apply enough medicine to cover the affected area. Rub in gently.

  • Do not cover unless directed otherwise by your doctor.

  • Wash your hands immediately after using Sulconazole Nitrate Solution, unless your hands are part of the treated area.

  • If you miss a dose of Sulconazole Nitrate Solution, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.

Ask your health care provider any questions you may have about how to use Sulconazole Nitrate Solution.



Important safety information:


  • Sulconazole Nitrate Solution is for external use only.

  • Do not get Sulconazole Nitrate Solution in your eyes.

  • Sulconazole Nitrate Solution may be harmful if swallowed. If you may have taken Sulconazole Nitrate Solution by mouth, contact your local poison control center or emergency room immediately.

  • Overuse of topical products may worsen your condition.

  • If your condition does not improve within 4 to 6 weeks or if it gets worse, check with your doctor.

  • Use Sulconazole Nitrate Solution with caution in the ELDERLY because they may be more sensitive to its effects.

  • Use Sulconazole Nitrate Solution with extreme caution in CHILDREN. Safety and effectiveness have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Sulconazole Nitrate Solution during pregnancy. It is unknown if Sulconazole Nitrate Solution is excreted in breast milk. If you are or will be breast-feeding while you are using Sulconazole Nitrate Solution, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Sulconazole Nitrate Solution:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Burning; itching; redness; stinging.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Sulconazole Nitrate side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Sulconazole Nitrate Solution:

Store Sulconazole Nitrate Solution at room temperature. Avoid temperatures above 104 degrees F (40 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Sulconazole Nitrate Solution out of the reach of children and away from pets.


General information:


  • If you have any questions about Sulconazole Nitrate Solution, please talk with your doctor, pharmacist, or other health care provider.

  • Sulconazole Nitrate Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Sulconazole Nitrate Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Sulconazole Nitrate resources


  • Sulconazole Nitrate Side Effects (in more detail)
  • Sulconazole Nitrate Use in Pregnancy & Breastfeeding
  • Sulconazole Nitrate Support Group
  • 0 Reviews for Sulconazole Nitrate - Add your own review/rating


Compare Sulconazole Nitrate with other medications


  • Impetigo
  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis
  • Tinea Versicolor

Sulf-10


Generic Name: sulfacetamide ophthalmic (SUL fa SEET a mide off THAL mik)

Brand Names: Bleph-10, Ocu-Sul 10, Ocu-Sul 15, Ocu-Sul 30, Sodium Sulamyd, Sulf-10, Sulfac 10%


What is Sulf-10 (sulfacetamide ophthalmic)?

Sulfacetamide ophthalmic is an antibiotic.


Sulfacetamide ophthalmic is used to treat bacterial infections of the eyes.


Sulfacetamide ophthalmic may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about Sulf-10 (sulfacetamide ophthalmic)?


Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in your eye.

Apply light pressure to the inside corner of your eye (near your nose) after each drop to prevent the fluid from draining down your tear ducts.


Who should not use Sulf-10 (sulfacetamide ophthalmic)?


Do not use sulfacetamide ophthalmic if you have a viral or fungal infection in your eye. It is used to treat infections caused by bacteria only.

Do not use sulfacetamide ophthalmic if you have ever had an allergic reaction to a sulfa-based drug.


It is not known whether sulfacetamide ophthalmic will harm an unborn baby. Do not use sulfacetamide ophthalmic without first talking to your doctor if you are pregnant. It is also not known whether sulfacetamide ophthalmic passes into breast milk. Do not use sulfacetamide ophthalmic without first talking to your doctor if you are breast-feeding a baby.

How should I use Sulf-10 (sulfacetamide ophthalmic)?


Use sulfacetamide ophthalmic eyedrops or ointment exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Wash your hands before using your eyedrops or ointment.


To apply the eye drops:



  • Shake the drops gently to be sure the medicine is well mixed. Tilt your head back slightly and pull down on your lower eyelid. Position the dropper above your eye. Look up and away from the dropper. Squeeze out a drop and close your eye. Apply gentle pressure to the inside corner of your eye (near your nose) for about 1 minute to prevent the liquid from draining down your tear duct. If you are using more than one drop in the same eye or drops in both eyes, repeat the process with about 5 minutes between drops.



To apply the ointment:



  • Hold the tube in your hand for a few minutes to warm it up so that the ointment comes out easily. Tilt your head back slightly and pull down gently on your lower eyelid. Apply a thin film of the ointment into your lower eyelid. Close your eye and roll your eyeball around in all directions for 1 to 2 minutes. If you are applying another eye medication, allow at least 10 minutes before the next application.




Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in your eye. Do not use any eyedrop that is discolored or has particles in it. Store sulfacetamide ophthalmic at room temperature away from moisture and heat. Keep the bottle or tube properly capped.

What happens if I miss a dose?


Apply the missed dose as soon as you remember. However, if it is almost time for your next regularly scheduled dose, skip the missed dose and apply the next one as directed. Do not use a double dose of this medication.


What happens if I overdose?


An overdose of this medication is unlikely to occur. If you do suspect an overdose, wash the eye with water and call an emergency room or poison control center near you. If the drops or ointment have been ingested, drink plenty of fluid and call an emergency center for advice.


What should I avoid while using Sulf-10 (sulfacetamide ophthalmic)?


Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in your eye. Use caution when driving, operating machinery, or performing other hazardous activities. Sulfacetamide ophthalmic may cause blurred vision. If you experience blurred vision, avoid these activities.

If you wear contact lenses, ask your doctor if you should wear them during treatment with sulfacetamide ophthalmic. After applying the medication, wait at least 15 minutes before inserting contact lenses, unless otherwise directed by your doctor.


Do not use other eye drops or medications during treatment with sulfacetamide ophthalmic unless otherwise directed by your doctor.

Sulf-10 (sulfacetamide ophthalmic) side effects


Serious side effects are not expected with this medication.


Commonly, some eye burning, stinging, irritation, itching, redness, blurred vision, eyelid itching, eyelid swelling, or sensitivity to light may occur.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Sulf-10 (sulfacetamide ophthalmic)?


Do not use this medication with other eyedrops containing nitrates (e.g., silver nitrate).


Do not use other eye drops or medications during treatment with sulfacetamide ophthalmic unless otherwise directed by your doctor.

Drugs other than those listed here may also interact with sulfacetamide ophthalmic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.



More Sulf-10 resources


  • Sulf-10 Side Effects (in more detail)
  • Sulf-10 Use in Pregnancy & Breastfeeding
  • Sulf-10 Drug Interactions
  • Sulf-10 Support Group
  • 0 Reviews for Sulf-10 - Add your own review/rating


  • Bleph-10 Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bleph-10 Prescribing Information (FDA)

  • Isopto Cetamide Prescribing Information (FDA)



Compare Sulf-10 with other medications


  • Conjunctivitis
  • Trachoma


Where can I get more information?


  • Your pharmacist has additional information about sulfacetamide ophthalmic written for health professionals that you may read.

See also: Sulf-10 side effects (in more detail)


stavudine


Generic Name: stavudine (STA vue deen)

Brand names: Zerit, Zerit XR


What is stavudine?

Stavudine is an antiviral medication that prevents human immunodeficiency virus (HIV) cells from multiplying in your body.


Stavudine is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Stavudine is not a cure for HIV or AIDS.


Stavudine may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about stavudine?


Some people have developed a life-threatening condition called lactic acidosis while taking stavudine. Early signs of lactic acidosis generally get worse over time and this condition can be fatal. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as: muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, stomach pain, nausea with vomiting, fast or uneven heart rate, dizziness, or feeling very weak or tired. Stavudine can also cause severe or life-threatening effects on your liver or pancreas. Call your doctor at once if you have any of these symptoms while taking stavudine: severe pain in your upper stomach spreading to your back, fast heart rate, nausea and vomiting, diarrhea, loss of appetite, low fever, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes). Before taking stavudine, tell your doctor if you have kidney disease, liver disease, a history of pancreatitis, or if you have used a medicine similar to stavudine in the past, such as abacavir (Ziagen), didanosine (Videx), lamivudine (Epivir), tenofovir (Viread), zalcitabine (Hivid), or zidovudine (Retrovir).

What should I discuss with my healthcare provider before taking stavudine?


Do not use this medication if you are allergic to stavudine.

If you have certain conditions, you may need a dose adjustment or special tests to safely take this medication. Before taking stavudine, tell your doctor if you are allergic to any drugs, or if you have:


  • kidney disease;

  • liver disease;


  • diabetes; or




  • a history of pancreatitis.




Some people have developed a life-threatening condition called lactic acidosis while taking stavudine. You may be more likely to develop lactic acidosis if you are overweight or have liver disease, if you are a woman, or if you have taken certain HIV or AIDS medications for a long time. Talk with your doctor about your individual risk. Stavudine can also cause severe or life-threatening effects on your liver or pancreas. Call your doctor at once if you have any of these symptoms while taking stavudine: severe pain in your upper stomach spreading to your back, fast heart rate, nausea and vomiting, diarrhea, loss of appetite, low fever, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes). FDA pregnancy category C. It is not known whether this medication is harmful to an unborn baby. HIV can be passed to the baby if the mother is not properly treated during pregnancy. Stavudine may also be more likely to cause lactic acidosis in a pregnant woman. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Take all of your HIV medicines as directed to control your infection while you are pregnant.

Your name may need to be listed on an antiviral pregnancy registry when you start using stavudine. The purpose of this registry is to track the outcome of the pregnancy and delivery to evaluate whether stavudine had any effect on the baby.


You should not breast-feed while you are using stavudine. Women with HIV or AIDS should not breast-feed at all. Even if your baby is born without HIV, you may still pass the virus to the baby in your breast milk.

If you have diabetes, you should know that the liquid form of this medication contains 50 milligrams (mg) of sucrose (sugar) per milliliter (mL). This is equal to 250 milligrams of sugar per teaspoon (5 mL) of stavudine liquid.


How should I take stavudine?


Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label.


This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


Take stavudine with a full glass of water.

Stavudine can be taken with or without food.


Shake the oral suspension (liquid) well just before you measure a dose. To be sure you get the correct dose, measure the liquid with a marked measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.

It is important to use stavudine regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.


HIV/AIDS is usually treated with a combination of different drugs. To best treat your condition, use all of your medications as directed by your doctor. Be sure to read the medication guide or patient instructions provided with each of your medications. Do not change your doses or medication schedule without advice from your doctor. Every person with HIV or AIDS should remain under the care of a doctor.


To be sure this medication is helping your condition, your blood will need to be tested on a regular basis. Your liver function may also need to be tested. Do not miss any visits to your doctor.


Store this medication at room temperature away from moisture and heat. Keep the bottle tightly closed. Keep the oral liquid in the refrigerator but do not let it freeze. Throw away any leftover medication after 30 days.

Throw away any unused or expired stavudine in a closed container or sealed bag. You may also ask your pharmacist where to locate a community pharmaceutical take-back disposal program.


What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine. Overdose symptoms may include numbness, burning, pain, or tingly feeling, nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes).

What should I avoid while taking stavudine?


Avoid drinking alcohol while taking stavudine. Alcohol may increase the risk of damage to the pancreas and/or liver.

Taking stavudine will not prevent you from passing HIV to other people through unprotected sex or sharing of needles. Talk with your doctor about safe methods of preventing HIV transmission during sex. Sharing drug or medicine needles is never safe, even for a healthy person.


Stavudine side effects


Stop using stavudine and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these other serious side effects:



  • liver damage - nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);




  • lactic acidosis - muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, nausea with vomiting, fast or uneven heart rate, dizziness, or feeling very weak or tired;




  • pancreatitis - severe pain in your upper stomach spreading to your back, nausea and vomiting, fast heart rate;




  • peripheral neuropathy - numbness, tingling, or pain in your hands or feet;




  • high blood sugar - increased thirst, fruity breath odor, increased urination, drowsiness, dry skin, nausea, and vomiting; or




  • any signs of infection such as fever, chills, sore throat, flu symptoms, easy bruising or bleeding (nosebleeds, bleeding gums), mouth sores, or unusual weakness.



Less serious side effects may include:



  • diarrhea;




  • muscle pain;




  • headache;




  • mild skin rash; or




  • changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and trunk).



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


Stavudine Dosing Information


Usual Adult Dose for HIV Infection:

Less than 60 kg: 30 mg orally every 12 hours
60 kg or more: 40 mg orally every 12 hours

Usual Adult Dose for Nonoccupational Exposure:

Less than 60 kg: 30 mg orally every 12 hours
60 kg or more: 40 mg orally every 12 hours

Duration: Prophylaxis should be initiated as soon as possible, within 72 hours of exposure, and continued for 28 days.

In general, the alternative regimens recommended for nonoccupational postexposure HIV prophylaxis include stavudine as part of protease inhibitor (PI)-based regimens.

Usual Pediatric Dose for HIV Infection:

Birth to 13 days: 0.5 mg/kg orally every 12 hours

14 days or older:
Less than 30 kg: 1 mg/kg orally every 12 hours
30 kg or more: Adult dosage recommended.


What other drugs will affect stavudine?


Before taking this medication, tell your doctor if you are using any of the following drugs:



  • didanosine (Videx);




  • doxorubicin (Adriamycin);




  • hydroxyurea (Droxia, Hydrea);




  • interferon-alfa (Roferon, Intron, Rebetron);




  • ribavirin (Rebetol, Ribasphere, Copegus Virazole); or




  • zidovudine (Retrovir).



This list is not complete and there may be other drugs that can interact with stavudine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More stavudine resources


  • Stavudine Side Effects (in more detail)
  • Stavudine Use in Pregnancy & Breastfeeding
  • Drug Images
  • Stavudine Drug Interactions
  • Stavudine Support Group
  • 0 Reviews for Stavudine - Add your own review/rating


  • stavudine Advanced Consumer (Micromedex) - Includes Dosage Information

  • Stavudine Professional Patient Advice (Wolters Kluwer)

  • Stavudine MedFacts Consumer Leaflet (Wolters Kluwer)

  • Stavudine Monograph (AHFS DI)

  • Zerit Prescribing Information (FDA)

  • Zerit Consumer Overview



Compare stavudine with other medications


  • HIV Infection
  • Nonoccupational Exposure


Where can I get more information?


  • Your pharmacist can provide more information about stavudine.

See also: stavudine side effects (in more detail)


Sulfacetamide Sodium/Sulfur with Cleanser


Pronunciation: SUL-fa-SET-a-mide SOE-dee-um/SUL-fur
Generic Name: Sulfacetamide Sodium/Sulfur with Cleanser
Brand Name: Examples include Rosanil and Sumadan


Sulfacetamide Sodium/Sulfur with Cleanser is used for:

Treating acne, rosacea, and seborrhea. It may also be used for other conditions as determined by your doctor.


Sulfacetamide Sodium/Sulfur with Cleanser is a combination sulfonamide antibiotic and keratolytic. It is packaged with a skin cleanser. It works by killing bacteria and shedding the top layer of skin to help treat acne


Do NOT use Sulfacetamide Sodium/Sulfur with Cleanser if:


  • you are allergic to any ingredient in Sulfacetamide Sodium/Sulfur with Cleanser

  • you have had a severe allergic reaction (eg, difficulty breathing, dizziness, hives, severe rash) to any other sulfonamide medicine (eg, sulfamethoxazole)

  • you have kidney disease

Contact your doctor or health care provider right away if any of these apply to you.



Before using Sulfacetamide Sodium/Sulfur with Cleanser:


Some medical conditions may interact with Sulfacetamide Sodium/Sulfur with Cleanser. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have eczema or a history of lupus

Some MEDICINES MAY INTERACT with Sulfacetamide Sodium/Sulfur with Cleanser. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Silver-containing products (eg, silver sulfadiazine) because they may decrease Sulfacetamide Sodium/Sulfur with Cleanser's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Sulfacetamide Sodium/Sulfur with Cleanser may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Sulfacetamide Sodium/Sulfur with Cleanser:


Use Sulfacetamide Sodium/Sulfur with Cleanser as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Gently wash the affected area using the provided skin cleanser, then dry.

  • Wet the skin and apply a generous amount of medicine to the affected area. Massage gently into the skin for 10 to 20 seconds, working into a full lather. Rinse well and pat dry.

  • Wash your hands right after using Sulfacetamide Sodium/Sulfur with Cleanser.

  • If dry skin occurs, you may rinse the medicine off the skin sooner or use the medicine less often, as directed by your doctor.

  • Sulfacetamide Sodium/Sulfur with Cleanser works best if it is used at the same time(s) each day.

  • Continue to use Sulfacetamide Sodium/Sulfur with Cleanser even if your condition improves. Do not miss any doses.

  • If you miss a dose of Sulfacetamide Sodium/Sulfur with Cleanser, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Sulfacetamide Sodium/Sulfur with Cleanser.



Important safety information:


  • Sulfacetamide Sodium/Sulfur with Cleanser is for external use only. Do not get it in your eyes, nose, or mouth. If you get it in any of these areas, rinse right away with cool tap water.

  • Talk with your doctor before you use any other medicines or cleansers on your skin.

  • Do not apply Sulfacetamide Sodium/Sulfur with Cleanser to open wounds or to damaged or burned skin without first checking with your doctor.

  • If you use topical products too often, your condition may become worse.

  • Sulfacetamide Sodium/Sulfur with Cleanser should be used with extreme caution in CHILDREN younger than 12 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Sulfacetamide Sodium/Sulfur with Cleanser while you are pregnant. It is not known if Sulfacetamide Sodium/Sulfur with Cleanser is found in breast milk after topical use. If you are or will be breast-feeding while you use Sulfacetamide Sodium/Sulfur with Cleanser, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Sulfacetamide Sodium/Sulfur with Cleanser:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Mild dryness, irritation, redness, scaling, stinging, or burning of the skin.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); cracked or extremely dry skin; fever; joint pain; severe diarrhea; severe skin irritation, redness, or scaling; sores in the mouth; swollen or blistered skin; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Sulfacetamide Sodium/Sulfur with side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Sulfacetamide Sodium/Sulfur with Cleanser may be harmful if swallowed. Symptoms of ingestion may include change in the amount of urine; nausea; vomiting.


Proper storage of Sulfacetamide Sodium/Sulfur with Cleanser:

Store Sulfacetamide Sodium/Sulfur with Cleanser at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Keep the container tightly closed. Store away from heat and light. Do not freeze. Keep Sulfacetamide Sodium/Sulfur with Cleanser out of the reach of children and away from pets.


General information:


  • If you have any questions about Sulfacetamide Sodium/Sulfur with Cleanser, please talk with your doctor, pharmacist, or other health care provider.

  • Sulfacetamide Sodium/Sulfur with Cleanser is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Sulfacetamide Sodium/Sulfur with Cleanser. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Sulfacetamide Sodium/Sulfur with Cleanser resources


  • Sulfacetamide Sodium/Sulfur with Cleanser Side Effects (in more detail)
  • Sulfacetamide Sodium/Sulfur with Cleanser Use in Pregnancy & Breastfeeding
  • Sulfacetamide Sodium/Sulfur with Cleanser Drug Interactions
  • Sulfacetamide Sodium/Sulfur with Cleanser Support Group
  • 18 Reviews for Sulfacetamide Sodium/Sulfur with - Add your own review/rating


Compare Sulfacetamide Sodium/Sulfur with Cleanser with other medications


  • Acne
  • Rosacea
  • Seborrheic Dermatitis